124 related articles for article (PubMed ID: 38040268)
1. Dysregulation of delta Np63 alpha in squamous cell carcinoma and its therapeutic targeting.
Samanta A; Saha P; Johnson O; Bishayee A; Sinha D
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189034. PubMed ID: 38040268
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
Nylander K; Coates PJ; Hall PA
Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
[TBL] [Abstract][Full Text] [Related]
3. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
Westfall MD; Mays DJ; Sniezek JC; Pietenpol JA
Mol Cell Biol; 2003 Apr; 23(7):2264-76. PubMed ID: 12640112
[TBL] [Abstract][Full Text] [Related]
4. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
[TBL] [Abstract][Full Text] [Related]
5. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
6. Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.
Fukunishi N; Katoh I; Tomimori Y; Tsukinoki K; Hata R; Nakao A; Ikawa Y; Kurata S
Neoplasia; 2010 Dec; 12(12):969-79. PubMed ID: 21170261
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
8. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.
Yoh KE; Regunath K; Guzman A; Lee SM; Pfister NT; Akanni O; Kaufman LJ; Prives C; Prywes R
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6107-E6116. PubMed ID: 27681615
[TBL] [Abstract][Full Text] [Related]
9. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms.
Koga F; Kawakami S; Kumagai J; Takizawa T; Ando N; Arai G; Kageyama Y; Kihara K
Br J Cancer; 2003 Mar; 88(5):740-7. PubMed ID: 12618884
[TBL] [Abstract][Full Text] [Related]
10. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
[TBL] [Abstract][Full Text] [Related]
11. CDK1 Promotes Epithelial-Mesenchymal Transition and Migration of Head and Neck Squamous Carcinoma Cells by Repressing ∆Np63α-Mediated Transcriptional Regulation.
Chen H; Hu K; Xie Y; Qi Y; Li W; He Y; Fan S; Liu W; Li C
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806389
[TBL] [Abstract][Full Text] [Related]
12. ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.
Huang Y; Sen T; Nagpal J; Upadhyay S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2008 Sep; 7(18):2846-55. PubMed ID: 18769144
[TBL] [Abstract][Full Text] [Related]
13. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
14. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
[TBL] [Abstract][Full Text] [Related]
15. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.
Compagnone M; Gatti V; Presutti D; Ruberti G; Fierro C; Markert EK; Vousden KH; Zhou H; Mauriello A; Anemone L; Bongiorno-Borbone L; Melino G; Peschiaroli A
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13254-13259. PubMed ID: 29162693
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
17. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
18. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis.
Barbieri CE; Tang LJ; Brown KA; Pietenpol JA
Cancer Res; 2006 Aug; 66(15):7589-97. PubMed ID: 16885358
[TBL] [Abstract][Full Text] [Related]
19. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
[TBL] [Abstract][Full Text] [Related]
20. p53 associates with and targets Delta Np63 into a protein degradation pathway.
Ratovitski EA; Patturajan M; Hibi K; Trink B; Yamaguchi K; Sidransky D
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1817-22. PubMed ID: 11172034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]